NCT00405431

Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?

Influence of Post-Operative Cyclosporine 0.05% (Restasis) on the Success of Glaucoma Filtering Surgery

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: Wills Eye · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether reducing inflammation of the surface of the eye with topical Restasis after glaucoma surgery will improve surgical outcomes and increase patient comfort.

Detailed description

Continued use of glaucoma drops can alter the outer surface of the eye and result in swelling and irritation, changing the structure of the eye. This structural change has been found to be a significant risk factor for the failure of glaucoma surgery. A comparison of how well patients do after glaucoma surgery depending on whether they use Restasis (the only prescription medication approved by the FDA for treating dry eye) or artificial tears (which can be purchased without a prescription) for 6 months following their surgery.

Conditions

• Glaucoma

Interventions

Type	Name	Description
DRUG	Restasis	1 drop in study eye twice a day X 6 months
DRUG	Endura (artificial tears)	1 drop in study eye twice a day X 6 months

Timeline

• Start date: 2004-03-01
• Primary completion: 2005-06-01
• Completion: 2007-11-01
• First posted: 2006-11-30
• Last updated: 2016-11-22

Locations

1 site across 1 country: United States